4
Changes in Ownership
Trevi Therapeutics, Inc. Filed Acc 0001209191-23-017148
Chief Commercial Officer acquired 18,750 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Simon Farrell · Chief Commercial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-03-07 | Exercise or conversion : show line 1 in the form | +18,750 | $0.51 | $9,581 | 39,400 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-03-07 | Exercise or conversion : show line 2 in the form Stock Option (right to buy) | −18,750 | 56,250 | D |
Loading xslF345X03/doc4.xml…